According to the current arrangement, there will be an intensive subscription of 14 new shares this week. On Monday (1Feb.1Feb. 02), Yuan Jie Science and Technology is the leader of domestic high-speed laser chips, and the issue price is 100.66 yuan/share. The top subscription only needs 35,000 yuan of Shanghai market value, which has the attribute of "meat standard". According to the prospectus, at present, Yuan Jie Science and Technology has achieved batch supply to the top ten mainstream optical module manufacturers at home and abroad, such as customers A 1, Hisense Broadband, Zhongji Xu Chuang, Bochuang Technology and Mingpu Optics and Magnetics, and the products are applied to the networks of the three major domestic operators and well-known foreign operators.
Capital Securities (12, 13), which will be applied for on Tuesday, is the first brokerage firm to obtain IPO approval from the CSRC this year, and will also become the 42nd A-share listed brokerage firm. Judging from the revenue and net profit in the past three years, Capital Securities is in the middle of the industry and its performance has steadily improved. According to the statistics of the Securities Industry Association, from 20 19 to 202 1 year, the company's operating income ranked 62nd, 63rd and 57th respectively in the industry. The net profit rankings are 5 1, 49, and 43 respectively.
In addition, the micro-conductive nano to be purchased this Wednesday (65438+February 14) is a leading domestic manufacturer of thin film deposition equipment, and Jiehuate is a leading domestic supplier of virtual IDM mode analog chips. Shanwaishan, which will be purchased this Thursday (65438+February 65438+May), is a leading manufacturer of blood purification equipment in China. Ning Chuan Bio, which will be purchased this Friday (65438+February 65438+June), is a leading enterprise of antibiotic intermediates.
Outlook:
Overview of the fundamentals of new shares this week
According to the current arrangement, if there is no change, there are 14 new shares available for subscription this week (February 12 to 16), including 5 in science and technology innovation board, 3 in Growth Enterprise Market, 5 in Beijing Stock Exchange and 0 in Shanghai Stock Exchange.
Monday
Yuan Jie Science and Technology:
The company focuses on the optical chip industry, and its main business is R&D, which designs, produces and sells optical chips. Its main products include 2.5G, 10G, 25G and higher-speed laser chip series products, which are mainly used in optical fiber access, 4G/5G mobile communication networks and data centers.
PE* adopts the caliber of "202 1 diluted P/E ratio before and after deducting non-recurring gains and losses", the same below.
Compared with PE*, the "static-non-front" caliber is adopted.
According to the Yuan Jie Science and Technology Prospectus, it is estimated that the net profit in 2022 will reach 654.38+0 billion yuan to 654.38+0.2 billion yuan, up by 4.95% to 25.93% year-on-year.
Hua Kai materials:
The company is mainly engaged in the research and development, production and sales of packaging materials for electronic components. Up to now, epoxy powder packaging materials and epoxy plastic packaging materials have been formed, as well as other materials products, which are mainly used in the fields of electronic components insulation packaging.
According to the material prospectus of Hua Kai, it is estimated that the net profit will reach 65,438+0,786.1.300 yuan to 65,438+0.96792 million yuan in 2022, a year-on-year decrease of 65,438+0.30% to 2.27%.
Kone technology:
The company is a high-tech enterprise specializing in research and development, production, sales and service of reducers. Since its establishment, the company has been focusing on the reducer industry. As one of the benchmark enterprises with obvious competitiveness in the field of industrial transmission system in China, we have been constantly standardizing and improving the technological innovation system with the development purpose of "specialization, modularization and serialization".
According to the prospectus of KONE Technology, it is estimated that the net profit will reach 965,438+0 million yuan to 98 million yuan in 2022, up by 0.50% to 8.23% year-on-year.
Hefei High-tech:
The company is a modular service provider engaged in research and development, production and sales of special accessories and molds for household appliances. The company's products are mainly used in the field of household appliances manufacturing, covering functional structural parts and exterior decorative parts such as refrigerators, televisions, air conditioners and washing machines.
According to the prospectus of Hefei Hi-Tech, in the first three quarters of 2022, the non-net profit was 24510.07 million yuan, a year-on-year increase of 15.43%.
Tuesday
Raytheon technology:
The company is a professional computer hardware equipment manufacturer, and its main products include notebook computers, desktops, peripherals and peripherals (including monitors, keyboards, mice, headphones, etc. ).
Raytheon Technology's prospectus shows that in the first three quarters of 2022, the non-net profit was 34.0329 million yuan, down 22.25% year-on-year.
Huami new materials:
The company is a high-tech enterprise specializing in the research, development, production and sales of rubber and plastic materials and their products. It is a professional and innovative national "little giant" enterprise. Our products are widely used in automobile, high-speed rail, construction machinery, petroleum machinery, aerospace and other fields.
According to the prospectus of Huami New Materials, it is estimated that the net profit from 65,438+0 to 65,438+0 in 2022 will be 37,093,700 yuan to 37,785,000 yuan, with a year-on-year change of-65,438+0.78% to 0.05%.
Capital security:
The company's main business scope includes: securities brokerage; Securities investment consulting; Financial advisers related to securities trading and securities investment activities; Securities underwriting and sponsorship; Securities self-management; Securities investment fund sales; Securities asset management; Margin financing and securities lending; Consignment of financial products; Provide intermediary business for futures companies.
According to the prospectus of Capital Securities, it is estimated that the net profit for the whole year of 2022 will be 637 million yuan to 696,5438+0 million yuan, with a year-on-year change of -25.86% to-65,438+095,5438+0%.
Wednesday
Ricky Zhizao:
The company is a professional provider of high-end process equipment, mainly engaged in the design, research and development and manufacture of large pressure vessels, intelligent integrated devices, special equipment for oil and gas drilling and production, special equipment for power processing, lithium batteries and nuclear energy installation.
According to the prospectus of Ricky Zhi Zhi, the net profit in the first three quarters of 2022 was 33.067 million yuan, up by1.31.81.00% year-on-year.
Micro-conductive nano:
Focusing on atomic layer deposition (ALD) technology, the company is mainly engaged in the research and development, production and sales of advanced micro-nano thin film deposition equipment, and provides advanced thin film deposition equipment, supporting products and services to downstream customers.
According to the micro-guide nano prospectus, it is estimated that the annual net profit in 2022 will be 23 million yuan to 42 million yuan, a year-on-year decrease of 5,065,438+02% to 8.92%.
Jewelry:
The company is an analog integrated circuit design enterprise with virtual IDM as its main business model, specializing in the research and development and sales of analog integrated circuits, and mainly adopting the company's own international advanced technology to design and manufacture chips. It is a "little giant" enterprise recognized by the Ministry of Industry and Information Technology.
According to Jewater's prospectus, it is estimated that the annual net profit in 2022 will be 65.438+36 billion yuan to 65.438+90 billion yuan, with a year-on-year change of -4.265.438+0% to 33.83%.
Thursday
The mountain beyond the mountain:
The issuer is a national high-tech enterprise specializing in the research and development, production and sales of blood purification equipment and consumables, and providing chain hemodialysis medical services. Our products are widely used to treat acute and chronic renal failure, uremia, multiple organ failure, poisoning and other diseases.
According to the prospectus of Shanwaishan, it is estimated that the net profit for the whole year of 2022 will be 42.39 million yuan to 63.58 million yuan, a year-on-year increase of 1 17.68% to 226.50%.
Zhucheng technology:
The company is a high-tech enterprise specializing in R&D, production and sales of electronic connectors, and has the ability to design, manufacture and assemble precision molds for electronic connectors. The company's products are mainly used in consumer appliances, intelligent terminals and so on.
According to the prospectus of Zhucheng Technology, it is estimated that the net profit in 2022 will reach 654.38+0.2 billion yuan to 654.38+0.25 billion yuan, a year-on-year change of -25.56% to -8.80%.
Friday
Fluorite net:
The company is committed to becoming a reliable smart home service provider and an Internet of Things cloud platform provider. Provide smart life solutions based on visual interaction for consumer users in smart home scenes; For industry customers, it provides an open cloud platform service for managing IOT devices.
According to the prospectus of fluorite.com, it is estimated that the net profit will reach 270 million yuan to 370 million yuan in 2022, with a year-on-year change of -40.00% to-18.00%.
Biology in Ning Chuan:
The issuer belongs to a pharmaceutical intermediate production enterprise, mainly engaged in the research and development and industrialization of biological fermentation technology. Issuer is one of the large-scale enterprises in the industrial application of bio-fermentation technology in China, and also one of the enterprises with leading scale, complete product range and advanced production technology in the field of antibiotic intermediates.
According to the biology prospectus of Ning Chuan, it is estimated that the net profit in 2022 will reach 382 million yuan to 465,438+0,654,388+0 billion yuan, up 243% to 269% year-on-year.